Retrospective analysis of securing the airway using fibreoptic intubation and the value of the transtracheal catheter (Ravussin cannula)

Retrospective analysis of securing the airway using fibreoptic intubation and the value of the transtracheal catheter (Ravussin cannula) - RetroRavIn

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027375

Enrollment

231

Registered

2022-03-24

Start date

2021-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult airway

Interventions

Group 1: Fiberoptic Intubation with Ravussin-Cannula Group 2: Fiberoptic Intubation without Ravussin-Cannula

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: fibreoptic intubation in the period between 01.01.2019 and 31.12.2020

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Oxygen drop defined as the difference between the highest and lowest measured peripheral oxygen saturation (SpO2 in %) during induction of anaesthesia.	—

Secondary

Measure	Time frame
- Frequency of critical desaturations (SpO2 <92%) - Frequency and type of complications during induction (e.g. malpunctions, haemodynamic instability, etc.).	—

Countries

Germany

Contacts

Public ContactSascha Treskatsch

Charité Campus Benjamin FranklinKlinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin

sascha.treskatsch@charite.de030 450 551522

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026